Sachs Autumn Life Sciences Week 2026

Eurobiomed invites you to participate in the Sachs Autumn Life Sciences Week 2026, a leading European investment event for the healthcare sector, bringing together investors, industry experts, and innovative life sciences companies.

Why participate?

• Meet investors, strategic partners, and industry experts through pre-arranged one-to-one meetings;
• Attend high-level conferences on market trends, innovation, and financing opportunities;
• Increase the international visibility of your company or project.

The event is structured around two complementary conferences: one dedicated to medical technologies and the other to biotechnology.

1st Annual European Healthcare Impact Summit (EHIS)

6 October 2026
Basel, Switzerland

Join the inaugural European Healthcare Impact Summit (EHIS), a flagship event bringing together nearly 300 international decision-makers from across the healthcare ecosystem, including pharmaceutical, biotechnology, medtech and digital health companies, investors, hospitals, scientists, key opinion leaders, and strategic partners.

The programme features keynote conferences, pre-arranged one-to-one meetings, networking sessions, and numerous partnership and investment opportunities focused on healthcare innovation.

The EHIS replaces both the 13th Annual HealthTech Investment Forum (Sachs HTIF), previously held in Basel, and the 8th Annual HealthTech Innovation Days (HTID), formerly hosted in Paris.

26th Annual Biotech in Europe Forum (BEF)

7–8 October 2026
Basel, Switzerland

Join the 26th Annual Biotech in Europe Forum (BEF), one of Europe's leading biotechnology investment and partnering events.

Engage with biotech executives, investors, global pharmaceutical companies, innovative biotech firms, and strategic partners through a programme of high-level conference sessions, pre-arranged one-to-one meetings, and extensive networking opportunities.

More than 50 innovative companies will showcase their projects to an audience of investors and potential partners, seeking funding and strategic collaborations.